Btr Capital Management Inc sold 7,467 shares as Gilead Sciences Inc (GILD)'s stock declined 8.05%. Finally, Jolley Asset Management LLC lifted its stake in shares of Gilead Sciences by 25.4% in the first quarter. Holowesko Partners Ltd who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $103.61B market cap company. (NASDAQ:GILD) traded up $1.10 during trading on Friday, reaching $79.32. About 13.75 million shares traded or 56.59% up from the average.
Gilead Sciences (NASDAQ:GILD) last announced its quarterly earnings data on Tuesday, February 6th. It has underperformed by 38.50% the S&P500.
Robertson Opportunity Capital Llc increased its stake in Nu Skin Enterprises Inc (NUS) by 8.36% based on its latest 2017Q3 regulatory filing with the SEC. The Monarch Capital Management Inc holds 55,559 shares with $4.50M value, up from 51,584 last quarter.
The stock increased 1.67% or $0.12 during the last trading session, reaching $7.31. Devon Energy Corporation (NYSE:DVN) has risen 13.24% since February 11, 2017 and is uptrending. It has outperformed by 24.43% the S&P500.
Investors sentiment decreased to 1.07 in 2017 Q3.
Among 9 analysts covering Bitauto Holdings (NYSE:BITA), 8 have Buy rating, 1 Sell and 0 Hold. It dropped, as 65 investors sold JPM shares while 767 reduced holdings. Excalibur stated it has 23,127 shares. Gulf International Natl Bank (Uk) Ltd invested 1.45% in JPMorgan Chase & Co. Tower Rech Ltd Company (Trc) accumulated 4,864 shares. Hbk Sorce Advisory Ltd owns 20,058 shares. (NYSE:V) for 420,417 shares.
Cornerstone Advisors Inc holds 1.18% of its portfolio in CBRE Clarion Global Real Estate Income Fund for 1.29 million shares. 7,786 are held by Rowland Co Inv Counsel Adv. Narwhal Cap Mngmt accumulated 93,174 shares or 2.21% of the stock. The biopharmaceutical company reported $2.56 EPS for the quarter, beating the Zacks' consensus estimate of $2.11 by $0.45. (NYSE:JPM). Afam Cap stated it has 118,268 shares. Valley Advisers, a Pennsylvania-based fund reported 1,578 shares. Goldman Sachs Gp holds 0.05% or 5.32 million shares. The rating was maintained by Stifel Nicolaus on Friday, April 29 with "Sell". Eagle Boston Mgmt invested 0.69% of its portfolio in Nu Skin Enterprises, Inc. (NASDAQ:GILD) were released by: Nasdaq.com and their article: "Earnings Reaction History: Gilead Sciences Inc., 63.6% Follow-Through ..." published on February 06, 2018 as well as Omaha.com's news article titled: "On Investments: CVS, Gilead Sciences hit the Casualty List" with publication date: January 16, 2018. The firm has "Outperform" rating by Oppenheimer given on Thursday, February 11. Therefore 81% are positive. Devon Energy Corporation had 117 analyst reports since July 21, 2015 according to SRatingsIntel. Bank of America boosted their price target on shares of Gilead Sciences from $82.00 to $87.00 and gave the company a "neutral" rating in a research report on Wednesday. On Friday, February 2 the stock rating was maintained by Tigress Financial with "Buy". Credit Suisse Group set a $80.00 target price on Gilead Sciences and gave the company a "hold" rating in a report on Wednesday, January 3rd. The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $5.71 billion. As per Friday, October 27, the company rating was maintained by Jefferies. (NYSE:V) rating on Tuesday, January 9. The stock has "Equal-Weight" rating by Morgan Stanley on Thursday, August 17. The rating was maintained by Wells Fargo with "Outperform" on Thursday, August 10. RBC Capital Markets maintained Campbell Soup Company (NYSE:CPB) rating on Friday, September 2.
Since August 18, 2017, it had 0 insider purchases, and 5 sales for $3.77 million activity. Another trade for 9,968 shares valued at $902,608 was sold by Friedman Stacey. In the last quarter, insiders sold 466,819 shares of company stock worth $36,740,240. Finally, Maxim Group raised Gilead Sciences from a "hold" rating to a "buy" rating and raised their target price for the stock from $73.67 to $94.00 in a report on Thursday, November 30th. Therefore 70% are positive.
Parnassus Investments decreased its stake in Gilead Sciences Inc. The firm earned "Overweight" rating on Friday, July 24 by Piper Jaffray. The company was reinitiated on Tuesday, July 11 by Jefferies. Hanson & Doremus Investment Management lifted its stake in shares of Gilead Sciences by 806.5% in the third quarter. TX reduced its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD) has "Hold" rating given on Monday, August 28 by Maxim Group. Deutsche Bank downgraded it to "Hold" rating and $28 target in Friday, March 11 report. The firm earned "Buy" rating on Monday, September 21 by Cowen & Co. Citigroup reissued a buy rating and set a $105.00 target price (up from $103.00) on shares of Gilead Sciences in a research report on Thursday.
Since August 30, 2017, it had 0 insider purchases, and 13 selling transactions for $51.09 million activity. The insider MARTIN JOHN C sold $6.09 million. Shares for $4.40M were sold by Washington Robin L on Thursday, September 7. 50,000 shares were sold by Alton Gregg H, worth $3.95M. Moreover, Schafer Cullen has 0% invested in Gilead Sciences, Inc. (NASDAQ:GILD) on Monday, January 18 to "Neutral" rating. It also upped Ishares Tr (IWM) stake by 16,515 shares and now owns 299,747 shares.
Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It dived, as 29 investors sold The Blackstone Group L.P. shares while 155 reduced holdings. 127 funds opened positions while 474 raised stakes. 272.94 million shares or 3.67% less from 283.35 million shares in 2017Q2 were reported. Foundry Prtnrs Ltd Llc reported 162,401 shares. Moreover, Silvercrest Asset Grp Limited Liability Company has 0.04% invested in Gilead Sciences, Inc.
Shares of Gilead Sciences (GILD) opened at 83.61 on Thursday. Tcw Group accumulated 1.52% or 2.36 million shares.
Brandywine Managers Llc holds 50.5% of its portfolio in Campbell Soup Company for 3.71 million shares. Bessemer, a New Jersey-based fund reported 1.34 million shares. Teacher Retirement Sys Of Texas holds 242,215 shares. Kwmg Limited Liability Corp has 24,980 shares for 0.67% of their portfolio. Wade G W And reported 9,645 shares. This is a boost from Gilead Sciences's previous quarterly dividend of $0.52. Hodges Cap Management holds 12,688 shares or 0.03% of its portfolio. New York-based Pinebridge Invests Limited Partnership has invested 0% in Gilead Sciences, Inc.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.